2023
DOI: 10.1016/j.xcrm.2023.100985
|View full text |Cite
|
Sign up to set email alerts
|

Repair what is lost: Neuroprotection through neural stem cells in progressive MS

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…It usually occurs in young people, and the mechanism of disease progression pathology is not yet clear. Most patients have relapses and remissions, and this relapsing-remitting treatment is mainly through immunoregulatory and immunosuppressive drugs [ 62 ]. Studies have shown that autologous hematopoietic stem cells (HSCs) transplantation treatment for MS patients has reduced the mortality rate from 7.3 % in 2000 to 0.2 % in 2016 [ 63 ].…”
Section: Validating the Safety And Efficacy Of Cellular Therapies Bas...mentioning
confidence: 99%
“…It usually occurs in young people, and the mechanism of disease progression pathology is not yet clear. Most patients have relapses and remissions, and this relapsing-remitting treatment is mainly through immunoregulatory and immunosuppressive drugs [ 62 ]. Studies have shown that autologous hematopoietic stem cells (HSCs) transplantation treatment for MS patients has reduced the mortality rate from 7.3 % in 2000 to 0.2 % in 2016 [ 63 ].…”
Section: Validating the Safety And Efficacy Of Cellular Therapies Bas...mentioning
confidence: 99%